These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 30584269)
1. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study. Labetoulle M; Schmickler S; Galarreta D; Böhringer D; Ogundele A; Guillon M; Baudouin C Clin Ophthalmol; 2018; 12():2499-2508. PubMed ID: 30584269 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency. Baudouin C; Galarreta DJ; Mrukwa-Kominek E; Böhringer D; Maurino V; Guillon M; Rossi GC; Van der Meulen IJ; Ogundele A; Labetoulle M Eur J Ophthalmol; 2017 Mar; 27(2):122-128. PubMed ID: 27791253 [TBL] [Abstract][Full Text] [Related]
3. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies. Srinivasan S; Garofalo R; Williams R Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Two Artificial Tears Containing Hyaluronic Acid for Post Cataract Surgery Dry Eye Disease: A Randomized Controlled Trial. Sun CC; Chan YH; Huang PW; Chen NN Ophthalmol Ther; 2024 Oct; 13(10):2615-2627. PubMed ID: 39127813 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of a hydroxypropyl guar/polyethylene glycol/propylene glycol-based lubricant eye-drop in patients with dry eye. Labetoulle M; Messmer EM; Pisella PJ; Ogundele A; Baudouin C Br J Ophthalmol; 2017 Apr; 101(4):487-492. PubMed ID: 27422973 [TBL] [Abstract][Full Text] [Related]
6. Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study. Bickle K; Miller JR; Tauber J; Awisi-Gyau D Ophthalmol Ther; 2024 Feb; 13(2):481-494. PubMed ID: 38079084 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease. Jerkins G; Greiner JV; Tong L; Tan J; Tauber J; Mearza A; Srinivasan S Clin Ophthalmol; 2020; 14():1665-1673. PubMed ID: 32606581 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial. Yeu E; Silverstein S; Guillon M; Schulze MM; Galarreta D; Srinivasan S; Manoj V Clin Ophthalmol; 2020; 14():2561-2570. PubMed ID: 32943837 [TBL] [Abstract][Full Text] [Related]
9. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. Rangarajan R; Kraybill B; Ogundele A; Ketelson HA J Ocul Pharmacol Ther; 2015 Oct; 31(8):491-7. PubMed ID: 26067908 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of polyethylene glycol-propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease. Aguilar A; Berra M; Trédicce J; Berra A Clin Ophthalmol; 2018; 12():1237-1243. PubMed ID: 30034217 [TBL] [Abstract][Full Text] [Related]
11. Tear film stability in patients with symptoms of dry eye after instillation of dual polymer hydroxypropyl guar/sodium hyaluronate vs single polymer sodium hyaluronate. Kanclerz P; Bazylczyk N; Radomski SA Int Ophthalmol; 2024 Apr; 44(1):193. PubMed ID: 38653918 [TBL] [Abstract][Full Text] [Related]
12. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease. Srinivasan S; Williams R Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study. Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410 [TBL] [Abstract][Full Text] [Related]
14. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. Rolando M; Autori S; Badino F; Barabino S J Ocul Pharmacol Ther; 2009 Jun; 25(3):271-8. PubMed ID: 19366323 [TBL] [Abstract][Full Text] [Related]
15. Performance and Safety of a Sodium Hyaluronate Tear Substitute with Polyethylene Glycol in Dry Eye Disease: A Multicenter, Investigator-Masked, Randomized, Noninferiority Trial. Labetoulle M; Mortemousque B; J Ocul Pharmacol Ther; 2022 Nov; 38(9):607-616. PubMed ID: 36269661 [No Abstract] [Full Text] [Related]
16. Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial. Asbell P; Vingrys AJ; Tan J; Ogundele A; Downie LE; Jerkins G; Shettle L Invest Ophthalmol Vis Sci; 2018 May; 59(6):2275-2280. PubMed ID: 29715369 [TBL] [Abstract][Full Text] [Related]
17. Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution. Fernandez KB; Epstein SP; Raynor GS; Sheyman AT; Massingale ML; Dentone PG; Landegger LD; Asbell PA Clin Ophthalmol; 2015; 9():1137-45. PubMed ID: 26170605 [TBL] [Abstract][Full Text] [Related]
18. Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution. Favuzza E; Cennamo M; Vicchio L; Giansanti F; Mencucci R Clin Ophthalmol; 2020; 14():1769-1775. PubMed ID: 32616996 [TBL] [Abstract][Full Text] [Related]
19. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. Davitt WF; Bloomenstein M; Christensen M; Martin AE J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478 [TBL] [Abstract][Full Text] [Related]
20. Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease. Calonge M; Sahyoun M; Baillif S; Gain P; Paw E; Mearza A; Cochener B Eur J Ophthalmol; 2023 Jan; 33(1):188-195. PubMed ID: 35450456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]